NCT05262556 2025-08-07NP-101 (TQ Formula) With Nivolumab and Ipilimumab in Advanced or Metastatic Extra-pulmonary Neuroendocrine CarcinomasCase Comprehensive Cancer CenterPhase 1 Active not recruiting15 enrolled
NCT04514497 2025-03-06Testing the Addition of an Anti-cancer Drug, BAY 1895344, to Usual Chemotherapy for Advanced Stage Solid Tumors, With a Specific Focus on Patients With Small Cell Lung Cancer, Poorly Differentiated Neuroendocrine Cancer, and Pancreatic CancerNational Cancer Institute (NCI)Phase 1 Active not recruiting28 enrolled